A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JX09 in Healthy Subjects.

Conditions: Resistant Hypertension Interventions: Drug: JX09 or placebo SAD; Drug: JX09 or placebo MAD; Drug: JX09 Sponsors: Ji Xing Pharmaceuticals Australia Pty Ltd; Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials